Caregivers and MDR-TB patients: Dataset for the importance of knowledge and behavior on drug resistance tuberculosis

Multidrug-resistant Tuberculosis (MDR-TB) is a type of Tuberculosis (TB) that is resistant to at least one or more of the main anti-TB drugs, namely Rifampin or Isoniazid, so this infection is more difficult to eliminate. Good knowledge and behavior of caregivers and patients can affect the success of treatment because they tend not to be late in taking treatment. In this data note we provide the details of a research database of 228 MDR-TB caregivers and patients underwent treatment from January 2020 to December 2021 in preferred hospital in West Java, Indonesia. The purposes of this publication are to describe the dataset for external researchers who may be interested in making use of it, and to detail the methods used to obtain the dataset to determine the level of knowledge and behavior of MDR-TB caregivers and patients regarding the disease through a validated questionnaire consisted of the knowledge and behavior distributed to respondents via online and offline.耐多药结核病（Multidrug-resistant Tuberculosis, MDR-TB）是指至少对利福平（Rifampin）、异烟肼（Isoniazid）这两种核心抗结核药物中的一种或多种产生耐药性的结核病（Tuberculosis, TB），此类感染的根除难度显著更高。照护者与患者具备良好的疾病认知及行为习惯，可有效影响治疗成功率，因为这能避免治疗延误。本数据笔记收录了2020年1月至2021年12月期间，印度尼西亚西爪哇省某选定医院内接受治疗的228名耐多药结核病照护者与患者的研究数据库详情。本次数据集发布的核心目的有二：其一，为有使用需求的外部研究人员详细说明该数据集的基本情况；其二，详述该数据集的获取方法——本研究通过一份经过效度验证的认知与行为问卷，以线上、线下结合的方式发放给受访者，以此评估耐多药结核病照护者与患者对该病的认知水平及行为表现。